Ciro R Rinaldi
Overview
Explore the profile of Ciro R Rinaldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Melo-Cardenas J, Bezavada L, Crawford J, Gurbuxani S, Cotton A, Guolian Kang , et al.
Blood
. 2022 Oct;
140(26):2805-2817.
PMID: 36283106
Myelofibrosis (MF) is a disease associated with high unmet medical needs because allogeneic stem cell transplantation is not an option for most patients, and JAK inhibitors are generally effective for...
2.
Roberto M, Pasqualone G, Di Donato N, Malik Z, Bhaiyat S, Caponio V, et al.
Am J Blood Res
. 2021 Apr;
11(1):84-92.
PMID: 33796394
Foetal spleen is described as a transient focus of haematopoiesis between the 3 and 5 month of gestation: this function is however entirely replaced by the bone marrow before the...
3.
Rinaldi C, Rinaldi P, Alagia A, Gemei M, Esposito N, Formiggini F, et al.
Blood
. 2010 Sep;
116(26):6023-6.
PMID: 20861460
Recently, Dawson et al identified a previously unrecognized nuclear role of JAK2 in the phosphorylation of histone H3 in hematopoietic cell lines. We searched nuclear JAK2 in total bone marrow...
4.
Rinaldi C, Rinaldi P, Gemei M, Grimaldi F, Battipaglia G, Del Vecchio L, et al.
Am J Hematol
. 2010 Apr;
85(5):383-6.
PMID: 20425802
No abstract available.
5.
Laricchia-Robbio L, Premanand K, Rinaldi C, Nucifora G
Cancer Res
. 2009 Feb;
69(4):1633-42.
PMID: 19208846
EVI1 is an oncogene inappropriately expressed in the bone marrow (BM) of approximately 10% of myelodysplastic syndrome (MDS) patients. This disease is characterized by severe anemia and multilineage myeloid dysplasia...
6.
Camera A, Rinaldi C, Palmieri S, Cantore N, Mele G, Mettivier V, et al.
Ann Hematol
. 2008 Aug;
88(2):151-8.
PMID: 18709502
A large proportion of adult patients with acute myeloid leukemia (AML) relapse after treatment, and some of them are resistant to primary induction chemotherapy. Sixty-one patients from seven hematological centers...
7.
Rinaldi C, Martinelli V, Rinaldi P, Ciancia R, Del Vecchio L
Leuk Lymphoma
. 2008 May;
49(7):1416-9.
PMID: 18452096
No abstract available.
8.
Senyuk V, Sinha K, Li D, Rinaldi C, Yanamandra S, Nucifora G
Cancer Res
. 2007 Jun;
67(12):5658-66.
PMID: 17575132
Recurring chromosomal translocations observed in human leukemia often result in the expression of fusion proteins that are DNA-binding transcription factors. These altered proteins acquire new dimerization properties that result in...
9.
Li D, Sinha K, Hay M, Rinaldi C, Saunthararajah Y, Nucifora G
J Biol Chem
. 2007 Mar;
282(18):13542-51.
PMID: 17355962
RUNX1 (AML1, CBFalpha2, PEBP2alphaB) is a transcription factor essential for the establishment of the hematopoietic stem cell. It is generally thought that RUNX1 exists as a monomer that regulates hematopoietic...
10.
Laricchia-Robbio L, Fazzina R, Li D, Rinaldi C, Sinha K, Chakraborty S, et al.
Mol Cell Biol
. 2006 Sep;
26(20):7658-66.
PMID: 16954386
EVI1 is an aggressive nuclear oncoprotein deregulated by recurring chromosomal abnormalities in myelodysplastic syndrome (MDS). The expression of the corresponding gene is a very poor prognostic marker for MDS patients...